Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001
Anabolic effects and safety assessments of TH9507, a growth hormone releasing factor (GRF) analog, in patients with COPD-associated wasting Source: Eur Respir J 2004; 24: Suppl. 48, 292s Year: 2004
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats Source: Eur Respir J 2011; 38: 870-877 Year: 2011
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Is serum leptin level a predictor for asthma? Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005
Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
Influence of glucocorticosteroids on free and bound metenkefaline levels in serum of children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 220s Year: 2002
Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1? Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Serum leptin – is it associated with levels of airway responsiveness? Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Effect of intravenous hydrocortisone on nocturnal airflow limitation in childhood asthma Source: Eur Respir J 2003; 21: 627-632 Year: 2003
Inhaled steroids in children: adrenal suppression and growth impairment Source: Eur Respir J 2002; 19: 985-988 Year: 2002
Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Effects of steroid treatment on serum leptin level and haemostatic parameters in COPD patients with normal body mass index Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006
Effects of insulin-like growth factor on nitrogen balance during hypoxic exposure Source: Eur Respir J 2002; 20: 293-299 Year: 2002